Home
Conditions
Adenocarcinoma

Clinical trial condition

Adenocarcinoma

Explore clinical trials studying Adenocarcinoma. Study availability and eligibility vary by location and protocol.

5,040 public trials 1,178 recruiting studies

Refine in advanced search Browse all conditions

Adenocarcinoma trial results

Completed

Arsenic Trioxide in Treating Patients With Metastatic Liver Cancer That Cannot Be Removed by Surgery

NCT00128596

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: UPMC Cancer Centers Pittsburgh, Pennsylvania, United States

View Trial Details

Completed

Omega-3 Fatty Acids in Treating Women With Newly Diagnosed Ductal Carcinoma In Situ and/or Atypical Ductal Hyperplasia

NCT00627276

Conditions: Adenocarcinoma, Breast Cancer, Breast Carcinoma In Situ, +14 more
Locations: Epic Imaging Portland, Oregon, United States

Knight Cancer Institute at Oregon Health and Science University Portland, Oregon, United States

View Trial Details

Completed

Biomarker Analysis in Sorafenib Treated Hepatocellular Carcinoma Patients

NCT01481805

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Samsung medical Center Seoul, South Korea

View Trial Details

Completed

Continuous Monitoring on the General Ward

NCT02933307

Conditions: Adenocarcinoma, Arthritis, Carcinoma, +31 more
Locations: Not specified

View Trial Details

Completed

Sunitinib Malate in Treating Patients With Iodine-Refractory Recurrent or Metastatic Thyroid Cancer

NCT00519896

Conditions: Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +26 more
Locations: Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

Vitamin Supplementation in NSCLC Patients on Pemetrexed Based Chemotherapy

NCT02679443

Conditions: Adenocarcinoma, Adenocarcinoma of Lung, Agranulocytosis, +19 more
Locations: PGIMER Chandigarh, India

View Trial Details

Completed

Clinical Trial of Dovitinib in First-line Metastatic or Locally Advanced Non-resectable Adrenocortical Carcinoma

NCT01514526

Conditions: Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +10 more
Locations: Complejo Hospitalario Universitario de Santiago Santiago de Compostela, A Coruña, Spain

Hospital Universitario Fundación de Alcorcón Alcorcón, Madrid, Spain

Hospital del Mar Barcelona, Spain

Hospital Universitario Reina Sofía Córdoba, Spain

View Trial Details

Completed

Phase III Sequential Open-label Study to Evaluate the Efficacy and Safety of Sorafenib Followed by Pazopanib Versus Pazopanib Followed by Sorafenib in the Treatment of Advanced / Metastatic Renal Cell Carcinoma (SWITCH-II)

NCT01613846

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Medizinische Universität Innsbruck Innsbruck, Austria

A. ö. Bezirkskrankenhaus Kufstein Kufstein, Austria

AKH Linz GmbH Linz, Austria

LKH Salzburg Salzburg, Austria

View all 72 locations

View Trial Details

Completed

Gemcitabine and Irinotecan in Treating Patients With Metastatic Kidney Cancer

NCT00401128

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Irinotecan Plus Gemcitabine in Treating Patients With Unresectable or Metastatic Solid Tumors

NCT00004095

Conditions: Adenocarcinoma, Bladder Cancer, Breast Cancer, +49 more
Locations: Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States

View Trial Details

Adenocarcinoma

Adenocarcinoma trial results

Related conditions